Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.
Publication
, Journal Article
Stryjewski, ME; Barriere, SL; Rubinstein, E; Genter, FC; Lentnek, AL; Magana-Aquino, M; Luna, CM; Niederman, MS; Torres, A; Corey, GR
Published in: Int J Antimicrob Agents
October 2013
Duke Scholars
Published In
Int J Antimicrob Agents
DOI
EISSN
1872-7913
Publication Date
October 2013
Volume
42
Issue
4
Start / End Page
367 / 369
Location
Netherlands
Related Subject Headings
- Vancomycin
- Treatment Outcome
- Pneumonia, Bacterial
- Microbiology
- Lipoglycopeptides
- Humans
- Cross Infection
- Bacteremia
- Anti-Bacterial Agents
- Aminoglycosides
Citation
APA
Chicago
ICMJE
MLA
NLM
Stryjewski, M. E., Barriere, S. L., Rubinstein, E., Genter, F. C., Lentnek, A. L., Magana-Aquino, M., … Corey, G. R. (2013). Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. Int J Antimicrob Agents, 42(4), 367–369. https://doi.org/10.1016/j.ijantimicag.2013.06.003
Stryjewski, Martin E., Steven L. Barriere, Ethan Rubinstein, Fredric C. Genter, Arnold L. Lentnek, Martin Magana-Aquino, Carlos M. Luna, Michael S. Niederman, Antoni Torres, and G Ralph Corey. “Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.” Int J Antimicrob Agents 42, no. 4 (October 2013): 367–69. https://doi.org/10.1016/j.ijantimicag.2013.06.003.
Stryjewski ME, Barriere SL, Rubinstein E, Genter FC, Lentnek AL, Magana-Aquino M, et al. Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. Int J Antimicrob Agents. 2013 Oct;42(4):367–9.
Stryjewski, Martin E., et al. “Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.” Int J Antimicrob Agents, vol. 42, no. 4, Oct. 2013, pp. 367–69. Pubmed, doi:10.1016/j.ijantimicag.2013.06.003.
Stryjewski ME, Barriere SL, Rubinstein E, Genter FC, Lentnek AL, Magana-Aquino M, Luna CM, Niederman MS, Torres A, Corey GR. Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. Int J Antimicrob Agents. 2013 Oct;42(4):367–369.
Published In
Int J Antimicrob Agents
DOI
EISSN
1872-7913
Publication Date
October 2013
Volume
42
Issue
4
Start / End Page
367 / 369
Location
Netherlands
Related Subject Headings
- Vancomycin
- Treatment Outcome
- Pneumonia, Bacterial
- Microbiology
- Lipoglycopeptides
- Humans
- Cross Infection
- Bacteremia
- Anti-Bacterial Agents
- Aminoglycosides